CiVi Biopharma ApS: Financial statements 2024
CVR: 38027794
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
CiVi Biopharma ApS (CVR 38027794) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 610,531 and a net result of DKK -1,410,204 compared with DKK -1,887,334 the year before. That is a decrease of 82.6% compared with the year before. Equity in the 2024 report amounted to DKK 77,815. The solvency ratio was 60.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 610,531
- Profit/Loss
- DKK -1,410,204
- Equity
- DKK 77,815
- Total Assets
- DKK 127,815
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 611K | -1.4M | 78K | 1 |
| 2023 | - | 3.5M | -1.9M | 1.5M | 1 |
| 2022 | - | 3.5M | 326K | 3.4M | 1 |
| 2021 | - | 4M | 344K | 3M | 1 |
| 2020 | - | 4.5M | 392K | 2.7M | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of October 22, 2024, REVISIONSFIRMAET EDELBO & LUND-LARSEN, STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of CiVi Biopharma ApS.
As of October 22, 2024, KPMG P/S has stepped down as auditor of CiVi Biopharma ApS.
As of September 4, 2024, Henrik Ørum has left the board of directors of CiVi Biopharma ApS.
As of September 4, 2024, Jess Thiersen is registered as liquidator of CiVi Biopharma ApS.
As of September 4, 2024, Martin Lavesen has stepped down as chairman of CiVi Biopharma ApS.
As of September 4, 2024, Jess Thiersen has stepped down as vice chairman of CiVi Biopharma ApS.
As of September 4, 2024, Henrik Ørum has stepped down as adm. dir. of CiVi Biopharma ApS.
On September 4, 2024, CiVi Biopharma ApS entered liquidation.
CiVi Biopharma ApS has published its annual report for 2023. Gross profit came to DKK 3,502,137, and the net result was DKK -1,887,334.
About CiVi Biopharma ApS
CiVi Biopharma ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company has been dissolved on 5 February 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named CiVi Biopharma A/S. The company has 1 employee (2024). In 2024, the company reported a gross profit of DKK 610,531 and a net result of DKK -1,410,204 compared with DKK -1,887,334 the year before. Equity in the 2024 report amounted to DKK 77,815.